Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US

Author： Paladino Joseph A.   Adelman Martin H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.8, 2007-01, pp. : 677-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia

By Bewick Thomas   Greenwood Sonia   Lim Wei Shen  

Clinical Medicine, Vol. 10, Iss. 6, 2010-12 ,pp. : 563-567

Royal College Of Physicians

Access to resources Recommend Favorite

Current treatment of community-acquired pneumonia

By Liapikou Adamantia  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1319-1332

Informa Healthcare

Access to resources Recommend Favorite

Comparative Tolerability of Intravenous Erythromycin and Clarithromycin in Hospitalised Patients with Community-Acquired Pneumonia: Results of a Double-Blind, Randomised, Prospective Study

By de Celis G.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

Elderly Patients with Community-Acquired Pneumonia: Optimal Treatment Strategies

By Thiem Ulrich  

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 519-537

Adis International

Access to resources Recommend Favorite

Intravenous/Oral Sequential Therapy in Patients Hospitalised with Community-Acquired Pneumonia: Which Patients, When and What Agents?

By Vogel F.  

Drugs, Vol. 62, Iss. 2, 2002-01 ,pp. : 309-317

Adis International

Access to resources Recommend Favorite